New strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts
- PMID: 20647474
- PMCID: PMC2932833
- DOI: 10.1158/1078-0432.CCR-09-1942
New strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts
Abstract
Pancreatic cancer (PC) is a highly lethal disease with complex etiology involving both environmental and genetic factors. Although cigarette smoking is known to explain 25% of cases, data from recent studies suggest that obesity and long-term type II diabetes are two major modifiable risk factors for PC. Furthermore, obesity and diabetes seem to affect the clinical outcome of patients with PC. Understanding the mechanistic effects of obesity and diabetes on the pancreas may identify new strategies for prevention or therapy. Experimental and epidemiologic evidence suggests that the antidiabetic drug metformin has protective antitumor activity in PC. In addition to insulin resistance and inflammation as mechanisms of carcinogenesis, obesity and diabetes are linked to impairments in endothelial function and coagulation status, which increase the risks of thrombosis and angiogenesis and, in turn, the risk of PC development and progression. The associations of the ABO blood group gene and NR5A2 gene variants with PC discovered by recent genome-wide association studies may link insulin resistance, inflammation, and thrombosis to pancreatic carcinogenesis. These exciting findings open new avenues for understanding the etiology of PC and provide opportunities for developing novel strategies for prevention and treatment of this disease.
Figures
Similar articles
-
The Impact of obesity and diabetes mellitus on pancreatic cancer: Molecular mechanisms and clinical perspectives.J Cell Mol Med. 2020 Jul;24(14):7706-7716. doi: 10.1111/jcmm.15413. Epub 2020 May 26. J Cell Mol Med. 2020. PMID: 32458441 Free PMC article. Review.
-
Diabetes and pancreatic cancer.Mol Carcinog. 2012 Jan;51(1):64-74. doi: 10.1002/mc.20771. Mol Carcinog. 2012. PMID: 22162232 Free PMC article.
-
Demographics, epidemiology, and inheritance of pancreatic ductal adenocarcinoma.Semin Oncol. 2015 Feb;42(1):8-18. doi: 10.1053/j.seminoncol.2014.12.002. Epub 2014 Dec 9. Semin Oncol. 2015. PMID: 25726048 Review.
-
Diabetes and pancreatic cancer.Endocr Relat Cancer. 2012 Sep 5;19(5):F9-F26. doi: 10.1530/ERC-12-0105. Print 2012 Oct. Endocr Relat Cancer. 2012. PMID: 22843556 Review.
-
[Diabetes and cancer risk: oncologic considerations].Orv Hetil. 2011 Jul 17;152(29):1144-55. doi: 10.1556/OH.2011.29158. Orv Hetil. 2011. PMID: 21712179 Review. Hungarian.
Cited by
-
The complexities of epidemiology and prevention of gastrointestinal cancers.Int J Mol Sci. 2012 Oct 1;13(10):12556-72. doi: 10.3390/ijms131012556. Int J Mol Sci. 2012. PMID: 23202913 Free PMC article. Review.
-
Metabolic disorder, inflammation, and deregulated molecular pathways converging in pancreatic cancer development: implications for new therapeutic strategies.Cancers (Basel). 2011 Jan 24;3(1):446-60. doi: 10.3390/cancers3010446. Cancers (Basel). 2011. PMID: 24212624 Free PMC article.
-
Pancreatic cancer organotypics: High throughput, preclinical models for pharmacological agent evaluation.World J Gastroenterol. 2014 Jul 14;20(26):8471-81. doi: 10.3748/wjg.v20.i26.8471. World J Gastroenterol. 2014. PMID: 25024603 Free PMC article. Review.
-
Hypoxia promotes C-X-C chemokine receptor type 4 expression through microRNA-150 in pancreatic cancer cells.Oncol Lett. 2015 Aug;10(2):835-840. doi: 10.3892/ol.2015.3344. Epub 2015 Jun 9. Oncol Lett. 2015. PMID: 26622579 Free PMC article.
-
Aberrant glycogen synthase kinase 3β in the development of pancreatic cancer.J Carcinog. 2012;11:15. doi: 10.4103/1477-3163.100866. Epub 2012 Sep 13. J Carcinog. 2012. PMID: 23230392 Free PMC article.
References
-
- Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–249. - PubMed
-
- Anderson K, Mack T, Silverman D. Cancer of the Pancreas. In: Schottenfeld D, Fraumeni J, editors. Cancer Epidemiology and Prevention. Second ed. New York: Oxford; 2006. pp. 721–762.
-
- Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;8:579–591. - PubMed
-
- Larsson SC, Orsini N, Wolk A. Body mass index and pancreatic cancer risk: a meta-analysis of prospective studies. Int J Cancer. 2007;120:1993–1998. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical